Kamada Stock Today
| KMDA Stock | USD 7.16 0.07 0.99% |
Performance18 of 100
| Odds Of DistressLess than 10
|
Kamada is trading at 7.16 as of the 18th of January 2025, a 0.99% up since the beginning of the trading day. The stock's open price was 7.09. Kamada has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 24th of January 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 31st of May 2013 | Category Healthcare | Classification Health Care |
It operates in two segments, Proprietary Products and Distribution. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. Kamada operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 57.49 M outstanding shares of which 23.2 K shares are now shorted by private and institutional investors with about 0.94 trading days to cover. More on Kamada
Moving against Kamada Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Kamada Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | David Tsur | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Tel Aviv 60, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsKamada can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Kamada's financial leverage. It provides some insight into what part of Kamada's total assets is financed by creditors.
| |||||
Kamada (KMDA) is traded on NASDAQ Exchange in USA. It is located in 2 Holzman Street, Rehovot, Israel, 7670402 and employs 378 people. Kamada is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 407.62 M. Kamada conducts business under Biotechnology sector and is part of Health Care industry. The entity has 57.49 M outstanding shares of which 23.2 K shares are now shorted by private and institutional investors with about 0.94 trading days to cover.
Kamada currently holds about 29.93 M in cash with 4.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69.
Check Kamada Probability Of Bankruptcy
Ownership AllocationKamada maintains a total of 57.49 Million outstanding shares. Over half of Kamada's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kamada Ownership Details
Kamada Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Of Tennessee, Treasury Department | 2023-06-30 | 0.0 |
Kamada Historical Income Statement
Kamada Stock Against Markets
Kamada Corporate Management
| LLB BA | General VP | Profile | |
| Boris Gorelik | Vice Programs | Profile | |
| Liron Reshef | Vice Resources | Profile | |
| Chaime Orlev | Chief Officer | Profile | |
| Yifat Esq | Gen Legal | Profile | |
| Amir London | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kamada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kamada. If investors know Kamada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kamada listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1 | Earnings Share 0.27 | Revenue Per Share | Quarterly Revenue Growth 0.134 | Return On Assets |
The market value of Kamada is measured differently than its book value, which is the value of Kamada that is recorded on the company's balance sheet. Investors also form their own opinion of Kamada's value that differs from its market value or its book value, called intrinsic value, which is Kamada's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kamada's market value can be influenced by many factors that don't directly affect Kamada's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kamada's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kamada is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kamada's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.